4
MARKET OVERVIEW
Unlock growth by leveraging patient-linked organoid screening and expanding into non-oncology applications.
55
4.2.1.1
GROWING DEMAND FOR HUMAN-RELEVANT DRUG TESTING AND NON-ANIMAL EVIDENCE
4.2.1.2
EXPANSION OF STANDARDIZED ORGANOID SUPPLY AND OUTSOURCED TESTING CAPACITY
4.2.2.1
HIGH MODEL ESTABLISHMENT COSTS AND LENGTHY EXPERIMENTAL TURNAROUND
4.2.3.1
PATIENT-LINKED ORGANOID SCREENING FOR FUNCTIONAL PRECISION ONCOLOGY
4.2.3.2
EXPANSION INTO IMMUNE AND NON-ONCOLOGY ORGANOID APPLICATIONS
4.2.4.1
REPRODUCIBILITY AND FIT-FOR-PURPOSE PREDICTIVE VALIDATION
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Navigate competitive pressures and macroeconomic shifts shaping the global human organoids market.
62
5.1
PORTER’S FIVE FORCES ANALYSIS
5.1.1
THREAT OF NEW ENTRANTS
5.1.2
THREAT OF SUBSTITUTES
5.1.3
BARGAINING POWER OF BUYERS
5.1.4
BARGAINING POWER OF SUPPLIERS
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE GLOBAL HUMAN ORGANOIDS MARKET
5.4.1
LIST OF KEY HUMAN ORGANOID MODEL AND SERVICE PROVIDERS
5.4.2
PRODUCTION SITES AND CAPABILITY DEVELOPMENTS OF KEY ORGANOID PROVIDERS
5.5.1
AVERAGE SELLING PRICE, BY PRODUC/ SERVICE
5.6
KEY CONFERENCES & EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.8
INVESTMENT & FUNDING SCENARIO
5.9
IMPACT OF 2025 US TARIFFS—GLOBAL HUMAN ORGANOIDS MARKET
5.9.2
PRICE IMPACT ANALYSIS
5.9.4
IMPACT ON END-USE INDUSTRIES
5.9.4.1
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
5.9.4.2
ACADEMIC AND RESEARCH INSTITUTES
5.9.4.3
CROS/CRDMOS AND OTHER RESEARCH END USERS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations revolutionize organoid technology, unlocking unprecedented market potential and future applications.
80
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
AI-ENABLED AND DIGITAL AUTOMATED AND HIGH-THROUGHPUT ORGANOID PLATFORMS
6.2
ADJACENT TECHNOLOGIES
6.2.1
ORGAN-ON-CHIP/MICROPHYSIOLOGICAL SYSTEMS
6.2.2
ADVANCED SPHEROID & 3D MICROTISSUE MODELS
6.3
COMPLEMENTARY TECHNOLOGIES
6.3.1
SPATIAL TRANSCRIPTOMICS AND SPATIAL OMICS
6.3.2
CRISPR/CAS GENOME EDITING
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5.1
TOP APPLICANTS/OWNERS (COMPANIES), FOR HUMAN ORGANOIDS PATENTS, 2015–2025
6.7
IMPACT OF AI/GEN AI ON THE GLOBAL HUMAN ORGANOIDS MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL HUMAN ORGANOIDS MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL HUMAN ORGANOIDS MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
Navigate complex global regulations with insights into sustainability-driven policy initiatives and eco-standards.
88
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYING BEHAVIOR
Decode buyer dynamics to navigate stakeholder influence and overcome adoption barriers effectively.
95
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2
KEY BUYING CRITERIA FOR HUMAN ORGANOID MODELS, BY END USER
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM END USERS
9
HUMAN ORGANOIDS MARKET, BY OFFERING
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 33 Data Tables
101
9.2.1
READY-TO-USE ORGANOID MODELS
9.2.1.1
INCREASING DEMAND FOR READY-TO-USE ORGANOID MODELS TO DRIVE MARKET GROWTH
9.2.2
CUSTOMIZABLE ORGANOID MODELS
9.2.2.1
RISING DEMAND FOR CUSTOMIZABLE ORGANOID MODELS TO SUPPORT MARKET GROWTH
9.3.1
MODEL DEVELOPMENT SERVICES
9.3.1.1
RISING DEMAND FOR CUSTOMIZED HUMAN ORGANOID MODELS TO DRIVE GROWTH OF MODEL DEVELOPMENT SERVICES
9.3.2
ORGANOID MODEL-BASED TESTING SERVICES
10
HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
117
10.2.1
RISING USE OF LIVER ORGANOID MODELS IN DRUG DISCOVERY AND TOXICITY TESTING TO DRIVE MARKET GROWTH
10.3
INTESTINAL & COLORECTAL MODELS
10.3.1
RISING USE OF INTESTINAL & COLORECTAL ORGANOID MODELS IN DISEASE MODELING AND DRUG SCREENING TO DRIVE MARKET GROWTH
10.4.1
RISING USE OF KIDNEY ORGANOID MODELS IN DISEASE MODELING AND DRUG TOXICITY TESTING TO DRIVE MARKET GROWTH
10.5.1
RISING USE OF PANCREATIC ORGANOID MODELS IN DISEASE MODELING AND DRUG DISCOVERY TO DRIVE MARKET GROWTH
10.6.1
RISING USE OF LUNG ORGANOID MODELS IN DISEASE MODELING AND DRUG SCREENING TO DRIVE MARKET GROWTH
10.7.1
RISING USE OF HEART ORGANOID MODELS IN CARDIOVASCULAR RESEARCH TO DRIVE MARKET GROWTH
10.8
OTHER ORGANOID MODELS
11
HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
133
11.2
ECM/MATRIGEL-BASED CULTURE
11.2.1
WIDESPREAD USE OF ECM/MATRIGEL-BASED CULTURE TO DRIVE HUMAN ORGANOIDS MARKET GROWTH
11.3
AIR-LIQUID INTERFACE CULTURE
11.3.1
INCREASING ADOPTION OF AIR-LIQUID INTERFACE CULTURE TO DRIVE MARKET GROWTH
11.4.1
RISING DEMAND FOR SCALABLE ORGANOID PRODUCTION TO DRIVE MARKET GROWTH
12
HUMAN ORGANOIDS MODELS MARKET, BY SOURCE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
143
12.2
PLURIPOTENT STEM CELLS
12.2.1
EXPANDING USE OF PLURIPOTENT STEM CELLS IN TISSUE-SPECIFIC ORGANOID DEVELOPMENT TO DRIVE MARKET GROWTH
12.3.1
RISING USE OF ADULT STEM CELLS FOR PHYSIOLOGICALLY RELEVANT ORGANOID MODELS TO DRIVE MARKET GROWTH
12.4
EMBRYONIC STEM CELLS
12.4.1
INCREASING USE OF EMBRYONIC STEM CELL-DERIVED ORGANOIDS IN DEVELOPMENTAL AND DISEASE RESEARCH TO SUPPORT MARKET GROWTH
13
HUMAN ORGANOIDS MARKET, BY DISEASE AREA
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 37 Data Tables
153
13.2.1
INCREASING ADOPTION OF TUMOR ORGANOIDS FOR DISEASE MODELING AND DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
13.3
LIVER DISEASES/HEPATOLOGICAL DISORDERS
13.3.1
INCREASING ADOPTION OF LIVER ORGANOIDS FOR DISEASE MODELING AND DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
13.4
GASTROINTESTINAL DISEASES
13.4.1
WIDE USAGE IN MODELING INFLAMMATORY BOWEL DISEASE AND MALIGNANCIES TO PROPEL MARKET
13.5
CARDIOVASCULAR DISEASES
13.5.1
RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET
13.6.1
USE OF ORGANOIDS IN DEVELOPING ANTIVIRAL DRUGS TO SUPPORT MARKET GROWTH
13.7
NEUROLOGICAL DISORDERS
13.7.1
GROWING INCIDENCE OF NEUROPSYCHIATRIC DISORDERS TO FUEL UPTAKE OF HUMAN ORGANOIDS
14
HUMAN ORGANOIDS MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 36 Data Tables
170
14.2
DRUG DISCOVERY & SCREENING
14.2.1
RISING USE OF HUMAN ORGANOIDS IN DRUG DISCOVERY AND SCREENING TO DRIVE MARKET GROWTH
14.3
DRUG TOXICITY & SAFETY TESTING
14.3.1
RISING USE OF HUMAN ORGANOIDS FOR DRUG TOXICITY AND SAFETY TESTING TO SUPPORT MARKET GROWTH
14.4.1
RISING APPLICATION OF HUMAN ORGANOIDS IN DISEASE MODELING TO DRIVE MARKET GROWTH
14.5
DEVELOPMENTAL BIOLOGY
14.5.1
INCREASING USE OF HUMAN ORGANOIDS IN DEVELOPMENTAL BIOLOGY TO SUPPORT MARKET GROWTH
14.6
PERSONALIZED MEDICINE
14.6.1
RISING ADOPTION OF PATIENT-DERIVED ORGANOIDS FOR PERSONALIZED MEDICINE TO DRIVE MARKET GROWTH
14.7
REGENERATIVE MEDICINE
14.7.1
EXPANDING APPLICATIONS OF HUMAN ORGANOIDS IN REGENERATIVE MEDICINE AND TISSUE ENGINEERING TO SUPPORT MARKET GROWTH
15
HUMAN ORGANOID MODELS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
186
15.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
15.2.1
INCREASING ADOPTION OF HUMAN ORGANOID MODELS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH
15.3
ACADEMIC & RESEARCH INSTITUTES
15.3.1
RISING USE OF HUMAN ORGANOIDS IN ACADEMIC AND RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
15.4.1
INCREASING OUTSOURCING OF RESEARCH ACTIVITIES TO DRIVE ADOPTION OF HUMAN ORGANOID MODELS BY CROS/CRDMOS
16
HUMAN ORGANOID SERVICES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 21 Data Tables
196
16.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
16.2.1
INCREASING OUTSOURCING OF ORGANOID DEVELOPMENT AND TESTING TO DRIVE MARKET GROWTH
16.3
ACADEMIC & RESEARCH INSTITUTES
16.3.1
RISING USE OF ORGANOID SERVICES IN ACADEMIC AND RESEARCH INSTITUTES TO DRIVE MARKET GROWTH
16.4.1
INCREASING OUTSOURCING OF PRECLINICAL RESEARCH TO DRIVE ADOPTION OF ORGANOID SERVICES BY CROS/CRDMOS
17
HUMAN ORGANOIDS MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 225 Data Tables.
206
17.2.1.1
INCREASING ADOPTION OF HUMAN ORGANOIDS IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
17.2.2.1
GROWING ORGANOID RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH IN CANADA
17.3.1.1
STRONG PHARMACEUTICAL AND RESEARCH ECOSYSTEM TO SUPPORT MARKET GROWTH
17.3.2.1
INCREASING ORGANOID RESEARCH AND DRUG DISCOVERY ACTIVITIES TO DRIVE MARKET GROWTH
17.3.3.1
GROWING LIFE SCIENCES RESEARCH AND ORGANOID APPLICATIONS TO SUPPORT MARKET GROWTH
17.3.4.1
EXPANDING BIOMEDICAL RESEARCH TO DRIVE ADOPTION OF HUMAN ORGANOIDS IN ITALY
17.3.5.1
RISING USE OF ORGANOIDS IN BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
17.3.6.1
EXPANDING ORGANOID RESEARCH ACROSS EUROPEAN COUNTRIES TO SUPPORT MARKET GROWTH
17.4.1.1
INCREASING PHARMACEUTICAL R&D AND ORGANOID RESEARCH TO DRIVE MARKET GROWTH
17.4.2.1
ADVANCING REGENERATIVE MEDICINE AND DRUG RESEARCH TO SUPPORT MARKET GROWTH
17.4.3.1
EXPANDING PHARMACEUTICAL RESEARCH AND BIOTECHNOLOGY ACTIVITIES TO DRIVE MARKET GROWTH
17.4.4.1
GROWING BIOTECHNOLOGY INVESTMENTS TO SUPPORT HUMAN ORGANOID MARKET GROWTH
17.4.5.1
INCREASING BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH IN AUSTRALIA
17.4.6
REST OF ASIA PACIFIC
17.4.6.1
RISING BIOTECHNOLOGY RESEARCH AND DRUG DEVELOPMENT ACTIVITIES TO SUPPORT MARKET GROWTH
17.5.1.1
GROWING BIOMEDICAL RESEARCH TO SUPPORT HUMAN ORGANOID MARKET GROWTH
17.5.2.1
EXPANDING PHARMACEUTICAL RESEARCH TO DRIVE MARKET GROWTH IN MEXICO
17.5.3
REST OF LATIN AMERICA
17.5.3.1
EXPANDING PHARMACEUTICAL RESEARCH TO DRIVE MARKET GROWTH IN MEXICO
17.6
MIDDLE EAST & AFRICA
17.6.1
GROWING INVESTMENTS IN LIFE SCIENCES RESEARCH TO SUPPORT MARKET GROWTH
18
COMPETITIVE LANDSCAPE
Discover top strategies and emerging leaders revolutionizing the human organoids market landscape.
311
18.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
18.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HUMAN ORGANOIDS MARKET
18.3
REVENUE ANALYSIS, 2023–2025
18.4
MARKET SHARE ANALYSIS, 2025
18.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
18.5.5
COMPANY FOOTPRINT, KEY PLAYERS, 2025
18.5.5.1
COMPANY FOOTPRINT
18.5.5.2
REGION FOOTPRINT
18.5.5.3
OFFERING FOOTPRINT
18.5.5.4
SOURCE FOOTPRINT
18.5.5.5
APPLICATION FOOTPRINT
18.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
18.6.1
PROGRESSIVE COMPANIES
18.6.2
RESPONSIVE COMPANIES
18.6.5
COMPETITIVE BENCHMARKING OF STARTUP/SME PLAYERS, 2025
18.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
18.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
18.7
COMPANY VALUATION AND FINANCIAL METRICS
18.8
BRAND COMPARATIVE ANALYSIS
18.9
COMPETITIVE SCENARIO
18.9.1
PRODUCT/ SERVICE LAUNCHES
18.9.3
OTHER DEVELOPMENTS
19
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
329
19.1.1.1
BUSINESS OVERVIEW
19.1.1.2
PRODUCTS/SERVICES OFFERED
19.1.1.3
RECENT DEVELOPMENTS
19.1.1.4.2
STRATEGIC CHOICES
19.1.1.4.3
WEAKNESSES AND COMPETITIVE THREATS
19.1.2
DANAHER CORPORATION
19.1.6
CHAMPIONS ONCOLOGY
19.1.9
ORGANOID SCIENCES, INC.
19.1.11
THERMO FISHER SCIENTIFIC INC.
19.1.12
BRUKER CORPORATION
19.1.13
CHARLES RIVER LABORATORIES
19.1.15
VIVOSIM LABS, INC.
19.1.16
STEMCELL TECHNOLOGIES
19.2.2
DISCOVERY LIFE SCIENCES
19.2.5
CENSO BIOTECHNOLOGIES LTD
19.2.7
PANDORUM TECHNOLOGIES PVT. LTD.
20
RESEARCH METHODOLOGY
382
20.2.1.1
KEY SECONDARY SOURCES
20.2.1.2
KEY DATA FROM SECONDARY RESEARCH
20.2.2.1
KEY DATA FROM PRIMARY SOURCES
20.2.2.2
BREAKDOWN OF PRIMARY INTERVIEWS
20.3
MARKET SIZE ESTIMATION
20.3.1
GLOBAL HUMAN ORGANOIDS MARKET ESTIMATION, 2025
20.3.1.1
APPROACH 1: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP)
20.3.1.2
APPROACH 2: SECONDARY RESEARCH
20.3.1.3
APPROACH 3: PRIMARY RESEARCH
20.3.1.4
KEY INDUSTRY INSIGHTS
20.3.1.5
APPROACH 3: MNM REPOSITORY ANALYSIS
20.3.2
SEGMENTAL MARKET SIZE ESTIMATION, 2025
20.4
MARKET GROWTH RATE PROJECTIONS
20.6
RESEARCH ASSUMPTIONS
20.7
RESEARCH LIMITATIONS
21.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
21.3
CUSTOMIZATION OPTIONS
TABLE 1
HUMAN ORGANOIDS MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
HUMAN ORGANOIDS MARKET: IMPACT ANALYSIS
TABLE 3
GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4
GLOBAL HUMAN ORGANOIDS MARKET: KEY MODEL AND SERVICE PROVIDERS
TABLE 5
GLOBAL HUMAN ORGANOIDS MARKET: PRODUCTION SITES AND CAPABILITY DEVELOPMENTS
TABLE 6
AVERAGE SELLING PRICE OF HUMAN ORGANOIDS, BY PRODUCT/ SERVICE, 2025
TABLE 7
GLOBAL HUMAN ORGANOIDS MARKET: KEY CONFERENCES & EVENTS, 2026–2027
TABLE 8
HUMAN ORGANOIDS MARKET: INDICATIVE LIST OF PATENTS, 2024–2025
TABLE 9
CASE STUDIES OF AI IMPLEMENTATION IN THE GLOBAL HUMAN ORGANOIDS MARKET
TABLE 10
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE GLOBAL HUMAN ORGANOIDS MARKET
TABLE 11
HUMAN ORGANOIDS REGULATORY GUIDANCE/FRAMEWORK, BY OFFERING
TABLE 12
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY MODEL TYPE (%)
TABLE 17
ILLUSTRATIVE BUYING CRITERIA, BY END USER
TABLE 18
HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 19
HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 20
HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 21
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 22
EUROPE: HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 23
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 24
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 25
READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 26
NORTH AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 27
EUROPE: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 28
ASIA PACIFIC: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 29
LATIN AMERICA: READY-TO-USE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 30
CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 31
NORTH AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 32
EUROPE: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 33
ASIA PACIFIC: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 34
LATIN AMERICA: CUSTOMIZABLE HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 35
HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 36
HUMAN ORGANOID MODEL SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 37
NORTH AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 38
EUROPE: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 39
ASIA PACIFIC: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 40
LATIN AMERICA: HUMAN ORGANOID MODEL SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 41
HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 42
NORTH AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 43
EUROPE: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 44
ASIA PACIFIC: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 45
LATIN AMERICA: HUMAN ORGANOID MODEL DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 46
HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 47
NORTH AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 48
EUROPE: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 49
ASIA PACIFIC: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 50
LATIN AMERICA: HUMAN ORGANOID MODEL-BASED TESTING SERVICES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 51
HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 52
LIVER MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 53
NORTH AMERICA: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 54
EUROPE: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 55
ASIA PACIFIC: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 56
LATIN AMERICA: LIVER MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 57
INTESTINAL & COLORECTAL MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 58
NORTH AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 59
EUROPE: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 60
ASIA PACIFIC: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 61
LATIN AMERICA: INTESTINAL & COLORECTAL MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 62
KIDNEY MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 63
NORTH AMERICA: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 64
EUROPE: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 65
ASIA PACIFIC: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 66
LATIN AMERICA: KIDNEY MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 67
PANCREATIC MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 68
NORTH AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 69
EUROPE: PANCREATIC MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 70
ASIA PACIFIC: PANCREATIC MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 71
LATIN AMERICA: PANCREATIC MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 72
LUNG MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 73
NORTH AMERICA: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 74
EUROPE: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 75
ASIA PACIFIC: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 76
LATIN AMERICA: LUNG MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 77
HEART MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 78
NORTH AMERICA: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 79
EUROPE: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 80
ASIA PACIFIC: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 81
LATIN AMERICA: HEART MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 82
OTHER HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 83
NORTH AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 84
EUROPE: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 85
ASIA PACIFIC: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 86
LATIN AMERICA: OTHER HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 87
HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 88
HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY REGION, 2023–2031 (USD MILLION)
TABLE 89
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 90
EUROPE: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 91
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 92
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ECM/MATRIGEL-BASED CULTURE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 93
HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY REGION, 2023–2031 (USD MILLION)
TABLE 94
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 95
EUROPE: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 96
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 97
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR AIR-LIQUID INTERFACE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 98
HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY REGION, 2023–2031 (USD MILLION)
TABLE 99
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 100
EUROPE: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 101
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 102
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR SUSPENSION, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 103
HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY REGION, 2023–2031 (USD MILLION)
TABLE 104
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 105
EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 106
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 107
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER CULTURE TYPES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 108
HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 109
PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 110
NORTH AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 111
EUROPE: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 112
ASIA PACIFIC: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 113
LATIN AMERICA: PLURIPOTENT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 114
ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 115
NORTH AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 116
EUROPE: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 117
ASIA PACIFIC: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 118
LATIN AMERICA: ADULT STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 119
EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 120
NORTH AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 121
EUROPE: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 122
ASIA PACIFIC: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 123
LATIN AMERICA: EMBRYONIC STEM CELLS-BASED HUMAN ORGANOID MODELS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 124
OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 125
NORTH AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 126
EUROPE: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 127
ASIA PACIFIC: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 128
LATIN AMERICA: OTHER HUMAN ORGANOID MODEL SOURCES MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 129
HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 130
INCIDENCE OF CANCER CASES WORLDWIDE, IN 2022 VS 2045, BY CANCER TYPE
TABLE 131
HUMAN ORGANOID MARKET FOR ONCOLOGY, BY REGION, 2023–2031 (USD MILLION)
TABLE 132
NORTH AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 133
EUROPE: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 134
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 135
LATIN AMERICA: HUMAN ORGANOID MARKET FOR ONCOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 136
HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY REGION, 2023–2031 (USD MILLION)
TABLE 137
NORTH AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 138
EUROPE: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 139
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 140
LATIN AMERICA: HUMAN ORGANOID MARKET FOR LIVER DISEASES/HEPATOLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 141
HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2031 (USD MILLION)
TABLE 142
NORTH AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 143
EUROPE: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 144
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 145
LATIN AMERICA: HUMAN ORGANOID MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 146
HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2023–2031 (USD MILLION)
TABLE 147
NORTH AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 148
EUROPE: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 149
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 150
LATIN AMERICA: HUMAN ORGANOID MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 151
HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2031 (USD MILLION)
TABLE 152
NORTH AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 153
EUROPE: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 154
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 155
LATIN AMERICA: HUMAN ORGANOID MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 156
HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2023–2031 (USD MILLION)
TABLE 157
NORTH AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 158
EUROPE: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 159
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 160
LATIN AMERICA: HUMAN ORGANOID MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 161
HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY REGION, 2023–2031 (USD MILLION)
TABLE 162
NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 163
EUROPE: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 164
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 165
LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER DISEASE AREAS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 166
HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 167
HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY REGION, 2023–2031 (USD MILLION)
TABLE 168
NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 169
EUROPE: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 170
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 171
LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG DISCOVERY & SCREENING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 172
HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY REGION, 2023–2031 (USD MILLION)
TABLE 173
NORTH AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 174
EUROPE: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 175
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 176
LATIN AMERICA: HUMAN ORGANOID MARKET FOR DRUG TOXICITY & SAFETY TESTING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 177
HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY REGION, 2023–2031 (USD MILLION)
TABLE 178
NORTH AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 179
EUROPE: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 180
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 181
LATIN AMERICA: HUMAN ORGANOID MARKET FOR DISEASE MODELING, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 182
HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY REGION, 2023–2031 (USD MILLION)
TABLE 183
NORTH AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 184
EUROPE: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 185
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 186
LATIN AMERICA: HUMAN ORGANOID MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 187
HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2023–2031 (USD MILLION)
TABLE 188
NORTH AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 189
EUROPE: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 190
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 191
LATIN AMERICA: HUMAN ORGANOID MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 192
HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY REGION, 2023–2031 (USD MILLION)
TABLE 193
NORTH AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 194
EUROPE: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 195
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 196
LATIN AMERICA: HUMAN ORGANOID MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 197
HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2031 (USD MILLION)
TABLE 198
NORTH AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 199
EUROPE: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 200
ASIA PACIFIC: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 201
LATIN AMERICA: HUMAN ORGANOID MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 202
HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 203
HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
TABLE 204
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 205
EUROPE: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 206
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 207
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 208
HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
TABLE 209
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 210
EUROPE: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 211
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 212
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 213
HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY REGION, 2023–2031 (USD MILLION)
TABLE 214
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 215
EUROPE: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 216
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 217
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 218
HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
TABLE 219
NORTH AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 220
EUROPE: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 221
ASIA PACIFIC: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 222
LATIN AMERICA: HUMAN ORGANOID MODELS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 223
HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 224
HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2031 (USD MILLION)
TABLE 225
NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 226
EUROPE: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 227
ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 228
LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 229
HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2031 (USD MILLION)
TABLE 230
NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 231
EUROPE: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 232
ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 233
LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 234
HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY REGION, 2023–2031 (USD MILLION)
TABLE 235
NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 236
EUROPE: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 237
ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 238
LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR CROS/CRDMOS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 239
HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2031 (USD MILLION)
TABLE 240
NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 241
EUROPE: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 242
ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 243
LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 244
HUMAN ORGANOIDS MARKET, BY REGION, 2023–2031 (USD MILLION)
TABLE 245
NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 246
NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 247
NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 248
NORTH AMERICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 249
NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 250
NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 251
NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 252
NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 253
NORTH AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 254
NORTH AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 255
NORTH AMERICA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 256
US: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 257
US: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 258
US: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 259
US: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 260
US: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 261
US: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 262
US: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 263
US: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 264
US: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 265
US: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 266
CANADA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 267
CANADA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 268
CANADA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 269
CANADA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 270
CANADA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 271
CANADA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 272
CANADA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 273
CANADA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 274
CANADA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 275
CANADA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 276
EUROPE: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 277
EUROPE: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 278
EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 279
EUROPE: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 280
EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 281
EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 282
EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 283
EUROPE: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 284
EUROPE: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 285
EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 286
EUROPE: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 287
GERMANY: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 288
GERMANY: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 289
GERMANY: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 290
GERMANY: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 291
GERMANY: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 292
GERMANY: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 293
GERMANY: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 294
GERMANY: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 295
GERMANY: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 296
GERMANY: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 297
UK: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 298
UK: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 299
UK: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 300
UK: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 301
UK: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 302
UK: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 303
UK: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 304
UK: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 305
UK: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 306
UK: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 307
FRANCE: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 308
FRANCE: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 309
FRANCE: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 310
FRANCE: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 311
FRANCE: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 312
FRANCE: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 313
FRANCE: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 314
FRANCE: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 315
FRANCE: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 316
FRANCE: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 317
ITALY: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 318
ITALY: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 319
ITALY: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 320
ITALY: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 321
ITALY: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 322
ITALY: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 323
ITALY: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 324
ITALY: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 325
ITALY: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 326
ITALY: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 327
SPAIN: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 328
SPAIN: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 329
SPAIN: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 330
SPAIN: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 331
SPAIN: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 332
SPAIN: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 333
SPAIN: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 334
SPAIN: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 335
SPAIN: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 336
SPAIN: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 337
REST OF EUROPE: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 338
REST OF EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 339
REST OF EUROPE: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 340
REST OF EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 341
REST OF EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 342
REST OF EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 343
REST OF EUROPE: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 344
REST OF EUROPE: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 345
REST OF EUROPE: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 346
REST OF EUROPE: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 347
ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 348
ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 349
ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 350
ASIA PACIFIC: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 351
ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 352
ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 353
ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 354
ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 355
ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 356
ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 357
ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 358
CHINA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 359
CHINA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 360
CHINA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 361
CHINA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 362
CHINA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 363
CHINA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 364
CHINA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 365
CHINA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 366
CHINA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 367
CHINA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 368
JAPAN: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 369
JAPAN: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 370
JAPAN: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 371
JAPAN: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 372
JAPAN: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 373
JAPAN: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 374
JAPAN: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 375
JAPAN: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 376
JAPAN: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 377
JAPAN: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 378
INDIA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 379
INDIA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 380
INDIA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 381
INDIA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 382
INDIA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 383
INDIA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 384
INDIA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 385
INDIA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 386
INDIA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 387
INDIA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 388
SOUTH KOREA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 389
SOUTH KOREA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 390
SOUTH KOREA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 391
SOUTH KOREA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 392
SOUTH KOREA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 393
SOUTH KOREA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 394
SOUTH KOREA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 395
SOUTH KOREA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 396
SOUTH KOREA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 397
SOUTH KOREA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 398
AUSTRALIA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 399
AUSTRALIA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 400
AUSTRALIA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 401
AUSTRALIA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 402
AUSTRALIA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 403
AUSTRALIA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 404
AUSTRALIA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 405
AUSTRALIA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 406
AUSTRALIA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 407
AUSTRALIA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 408
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 409
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 410
REST OF ASIA PACIFIC: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 411
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 412
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 413
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 414
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 415
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 416
REST OF ASIA PACIFIC: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 417
REST OF ASIA PACIFIC: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 418
LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY COUNTRY, 2023–2031 (USD MILLION)
TABLE 419
LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 420
LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 421
LATIN AMERICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 422
LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 423
LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 424
LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 425
LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 426
LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 427
LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 428
LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 429
BRAZIL: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 430
BRAZIL: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 431
BRAZIL: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 432
BRAZIL: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 433
BRAZIL: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 434
BRAZIL: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 435
BRAZIL: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 436
BRAZIL: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 437
BRAZIL: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 438
BRAZIL: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 439
MEXICO: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 440
MEXICO: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 441
MEXICO: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 442
MEXICO: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 443
MEXICO: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 444
MEXICO: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 445
MEXICO: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 446
MEXICO: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 447
MEXICO: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 448
MEXICO: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 449
REST OF LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 450
REST OF LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 451
REST OF LATIN AMERICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 452
REST OF LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 453
REST OF LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 454
REST OF LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 455
REST OF LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 456
REST OF LATIN AMERICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 457
REST OF LATIN AMERICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 458
REST OF LATIN AMERICA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 459
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY OFFERING, 2023–2031 (USD MILLION)
TABLE 460
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MODELS MARKET, BY TYPE, 2023–2031 (USD MILLION)
TABLE 461
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS SERVICES MARKET, BY SERVICE TYPE, 2023–2031 (USD MILLION)
TABLE 462
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MODELS MARKET, BY MODEL TYPE, 2023–2031 (USD MILLION)
TABLE 463
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MODELS MARKET, BY CULTURE TYPE, 2023–2031 (USD MILLION)
TABLE 464
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MODELS MARKET, BY SOURCE, 2023–2031 (USD MILLION)
TABLE 465
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY DISEASE AREA, 2023–2031 (USD MILLION)
TABLE 466
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MARKET, BY APPLICATION, 2023–2031 (USD MILLION)
TABLE 467
MIDDLE EAST & AFRICA: HUMAN ORGANOIDS MODELS MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 468
MIDDLE EAST & AFRICA: HUMAN ORGANOID SERVICES MARKET, BY END USER, 2023–2031 (USD MILLION)
TABLE 469
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HUMAN ORGANOIDS MARKET
TABLE 470
HUMAN ORGANOIDS MARKET: DEGREE OF COMPETITION
TABLE 471
HUMAN ORGANOIDS MARKET: REGION FOOTPRINT
TABLE 472
HUMAN ORGANOIDS MARKET: OFFERING FOOTPRINT
TABLE 473
HUMAN ORGANOIDS MARKET: SOURCE FOOTPRINT
TABLE 474
HUMAN ORGANOIDS MARKET: APPLICATION FOOTPRINT
TABLE 475
HUMAN ORGANOIDS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 476
HUMAN ORGANOIDS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
TABLE 477
HUMAN ORGANOIDS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 478
HUMAN ORGANOIDS MARKET: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 479
HUMAN ORGANOIDS MARKET: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 480
MERCK: COMPANY OVERVIEW
TABLE 481
MERCK: PRODUCTS/SERVICES OFFERED
TABLE 482
MERCK: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 483
MERCK: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 484
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 485
DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 486
DANAHER CORPORATION: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 487
SAMSUNG BIOLOGICS: COMPANY OVERVIEW
TABLE 488
SAMSUNG BIOLOGICS: PRODUCTS/SERVICES OFFERED
TABLE 489
SAMSUNG BIOLOGICS: SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 490
WUXI APPTEC: COMPANY OVERVIEW
TABLE 491
WUXI APPTEC: PRODUCTS/SERVICES OFFERED
TABLE 492
WUXI APPTEC: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 493
EVOTEC SE: COMPANY OVERVIEW
TABLE 494
EVOTEC SE: PRODUCTS/SERVICES OFFERED
TABLE 495
EVOTEC SE: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 496
CHAMPIONS ONCOLOGY: COMPANY OVERVIEW
TABLE 497
CHAMPIONS ONCOLOGY: PRODUCTS/SERVICES OFFERED
TABLE 498
CHAMPIONS ONCOLOGY: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 499
ACROBIOSYSTEMS: COMPANY OVERVIEW
TABLE 500
ACROBIOSYSTEMS: PRODUCTS/SERVICES OFFERED
TABLE 501
BIOMORGAN: COMPANY OVERVIEW
TABLE 502
BIOMORGAN: PRODUCTS/SERVICES OFFERED
TABLE 503
BIOMORGAN: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 504
ORGANOID SCIENCES, INC.: COMPANY OVERVIEW
TABLE 505
ORGANOID SCIENCES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 506
ORGANOID SCIENCES, INC.: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 507
ORGANOID SCIENCES, INC.: OTHER DEVELOPMENTS, JANUARY 2023–SEPTEMBER 2026
TABLE 508
JSR CORPORATION: COMPANY OVERVIEW
TABLE 509
JSR CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 510
JSR CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 511
THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
TABLE 512
THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 513
THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 514
THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 515
BRUKER CORPORATION: COMPANY OVERVIEW
TABLE 516
BRUKER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 517
BRUKER CORPORATION: PRODUCT & SERVICE LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 518
BRUKER CORPORATION: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 519
CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
TABLE 520
CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 521
PHARMARON: COMPANY OVERVIEW
TABLE 522
PHARMARON: PRODUCTS/SERVICES OFFERED
TABLE 523
VIVOSIM LABS, INC.: COMPANY OVERVIEW
TABLE 524
VIVOSIM LABS, INC.: PRODUCTS/SERVICES OFFERED
TABLE 525
VIVOSIM LABS, INC.: PRODUCT LAUNCHES, JANUARY 2023–SEPTEMBER 2026
TABLE 526
VIVOSIM LABS, INC.: DEALS, JANUARY 2023–SEPTEMBER 2026
TABLE 527
STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 528
STEMCELL TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
TABLE 529
STEMCELL TECHNOLOGIES: EXPANSIONS, JANUARY 2023–SEPTEMBER 2026
TABLE 530
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 531
RISK ASSESSMENT: HUMAN ORGANOIDS MARKET
FIGURE 1
HUMAN ORGANOIDS MARKET SEGMENTATION
FIGURE 2
HUMAN ORGANOIDS MARKET: YEARS CONSIDERED
FIGURE 4
GLOBAL HUMAN ORGANOID MODELS MARKET, 2023–2031
FIGURE 5
GLOBAL HUMAN ORGANOID SERVICES MARKET, 2023–2031
FIGURE 6
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HUMAN ORGANOIDS MARKET, 2023–2026
FIGURE 7
DISRUPTIONS INFLUENCING GROWTH OF HUMAN ORGANOIDS MARKET
FIGURE 8
HIGH-GROWTH SEGMENTS IN HUMAN ORGANOIDS MARKET, 2026–2031
FIGURE 9
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID MODELS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 10
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN HUMAN ORGANOID SERVICES MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 11
INCREASING ADOPTION OF HUMAN ORGANOID MODELS IN DRUG DISCOVERY TO PROPEL THE HUMAN ORGANOIDS MARKET
FIGURE 12
US AND SERVICES ACCOUNTED FOR LARGEST SHARE OF THE HUMAN ORGANOIDS MARKET IN NORTH AMERICA IN 2025
FIGURE 13
ASIA PACIFIC LIKELY TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD
FIGURE 14
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 15
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 16
HUMAN ORGANOIDS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17
GLOBAL HUMAN ORGANOIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 18
GLOBAL HUMAN ORGANOID MODELS MARKET: VALUE CHAIN ANALYSIS
FIGURE 19
GLOBAL HUMAN ORGANOIDS SERVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 20
GLOBAL HUMAN ORGANOIDS MARKET: ECOSYSTEM ANALYSIS
FIGURE 21
HUMAN ORGANOIDS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 22
TOP APPLICANTS & OWNERS (COMPANIES) FOR HUMAN ORGANOIDS PATENTS, 2015–DECEMBER 2025
FIGURE 23
IMPACT OF AI/GEN AI ON THE GLOBAL HUMAN ORGANOIDS MARKET
FIGURE 24
ILLUSTRATIVE STAKEHOLDER INFLUENCE, BY OFFERING
FIGURE 25
ILLUSTRATIVE BUYING PRIORITIES, BY END USER
FIGURE 26
NORTH AMERICA: HUMAN ORGANOIDS MARKET SNAPSHOT
FIGURE 27
ASIA PACIFIC: HUMAN ORGANOIDS MARKET SNAPSHOT
FIGURE 28
REVENUE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET (2023–2025)
FIGURE 29
MARKET SHARE ANALYSIS OF KEY PLAYERS IN HUMAN ORGANOIDS MARKET (2025)
FIGURE 30
HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 31
HUMAN ORGANOIDS MARKET: COMPANY FOOTPRINT
FIGURE 32
HUMAN ORGANOIDS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 33
EV/EBITDA OF KEY VENDORS
FIGURE 34
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 35
HUMAN ORGANOIDS MARKET: BRAND COMPARISON
FIGURE 36
MERCK: COMPANY SNAPSHOT
FIGURE 37
DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 38
SAMSUNG BIOLOGICS: COMPANY SNAPSHOT
FIGURE 39
WUXI APPTEC: COMPANY SNAPSHOT
FIGURE 40
EVOTEC SE: COMPANY SNAPSHOT
FIGURE 41
ACROBIOSYSTEMS: COMPANY SNAPSHOT
FIGURE 42
ORGANOID SCIENCES, INC.: COMPANY SNAPSHOT
FIGURE 43
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 44
BRUKER CORPORATION: COMPANY SNAPSHOT
FIGURE 45
CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
FIGURE 46
PHARMARON: COMPANY SNAPSHOT
FIGURE 47
HUMAN ORGANOIDS MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 48
HUMAN OGRANOIDS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 49
GLOBAL HUMAN ORGANOIDS MARKET ESTIMATION, 2025
FIGURE 50
HUMAN ORGANOIDS MARKET: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH) (2025)
FIGURE 51
HUMAN ORGANOIDS MARKET: INSIGHTS FROM PRIMARIES
FIGURE 52
SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
FIGURE 53
HUMAN ORGANOIDS MARKET: CAGR PROJECTIONS
FIGURE 54
DATA TRIANGULATION METHODOLOGY
Growth opportunities and latent adjacency in Human Organoids Market